Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs [Yahoo! Finance]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
Haemonetics' Plasma business unit focuses on the collection of source plasma for pharmaceutical manufacturers using apheresis devices that only collect plasma. The demand for source plasma has been growing due to an expanding end-user market for plasma-derived biopharmaceuticals. The business also offers software solutions to support the operations of dedicated source plasma collection centers. Plasma revenues grew 8% in the third quarter of fiscal 2024, driven primarily by volume. The collection environment in the United States continued to be favorable, with disposables growing 7% in the quarter and 17% year to date. The rollout of Persona — the company's proprietary technology proven to increase yield from 9% to 12% on average — continues to gain momentum, with more than 25 million collections. Haemonetics' hospital portfolio is evolving and helping to create new opportunities for growth and diversification. Each of the four product lines has a leading market position and a mi
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]Yahoo! Finance
- Haemonetics Corporation (NYSE:HAE) Q4 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) had its price target raised by analysts at JMP Securities from $115.00 to $125.00. They now have a "market outperform" rating on the stock.MarketBeat
- Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) had its price target raised by analysts at Barrington Research from $105.00 to $107.00. They now have an "outperform" rating on the stock.MarketBeat
HAE
Earnings
- 5/9/24 - Beat
HAE
Sec Filings
- 5/9/24 - Form 8-K
- 5/8/24 - Form 4
- 5/6/24 - Form 4
- HAE's page on the SEC website